CTSI News

The 8^th annual Duke CTSA KL2 symposium was held on Tuesday, June 14.  A virtual event since 2020, the symposium features presentations from the graduat

Four Duke National Clinician Scholars Program (NCSP) participants recently attended the 2022 AcademyHealth Annual Research Meeting, where they presented on research they have conducted as part of the Duke NCSP program.

Duke CTSI, the Duke University School of Medicine, and

Chronically stressful conditions of daily life such as racism, pollution, and poverty have a direct impact on the cellular mechanisms

KANNAPOLIS, N.C.—When her lower back started to hurt, Shantela Carter joined Duke’s new study at the North Carolina Research Campus in Kannapolis.

Preliminary results from the ACTIV-1 Immune Modulator clinical trial show that immune modulator drugs, infliximab and abatacept, substantially improved clinical status and reduced death

The Duke Clinical and Translational Science Institute (CTSI) has announced a new opportunity for Duke investigators to obtain biospecimens from the MURDOCK Study for research.

Nadine Barrett, PhD, director of t

The Duke CTSI Community Engaged Research Initiative (CERI) team is delighted to announce the recipients of its 2022-23 Population Health Improvement Awards. These annua

CTSI-supported research from Duke and North Carolina Central University could provide women with a new, non-invasive option for treating a common health issue.